Thalia Therapeutics plc (AIM: THAT)*: Acquisition & £2.75m fundraiseCoiled Therapeutics plc (AIM: COIL)*: Appointment of Craig Tooman as Independent NED Beximco Pharmaceuticals plc (AIM: BXP)*: Market update
24 Jun 2026
SP Angel Healthcare Conditions
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
SP Angel Healthcare Conditions
Beximco Pharmaceuticals Plc Sponsored GDR RegS (BXP:LON), 50.0 | Coiled Therapeutics Plc (COIL:LON), 10.0 | Thalia Therapeutics PLC (THAT:LON), 0.6
- Published:
24 Jun 2026 -
Author:
Vadim Alexandre | Greg Pave -
Pages:
4 -
Thalia Therapeutics plc (AIM: THAT)*: Acquisition & £2.75m fundraiseCoiled Therapeutics plc (AIM: COIL)*: Appointment of Craig Tooman as Independent NED Beximco Pharmaceuticals plc (AIM: BXP)*: Market update